Genmab
GMAB
GMAB
226 hedge funds and large institutions have $1.72B invested in Genmab in 2020 Q4 according to their latest regulatory filings, with 52 funds opening new positions, 85 increasing their positions, 63 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
14% more funds holding
Funds holding: 198 → 226 (+28)
1.83% more ownership
Funds ownership: 62.58% → 64.42% (+1.8%)
4% more call options, than puts
Call options by funds: $3.57M | Put options by funds: $3.44M
Holders
226
Holding in Top 10
2
Calls
$3.57M
Puts
$3.44M
Top Buyers
1 | +$21.9M | |
2 | +$14.9M | |
3 | +$14.4M | |
4 |
Jennison Associates
New York
|
+$14.2M |
5 |
![]()
1832 Asset Management
Toronto,
Ontario, Canada
|
+$11.4M |
Top Sellers
1 | -$18.3M | |
2 | -$14.3M | |
3 | -$14.1M | |
4 |
Morgan Stanley
New York
|
-$13.2M |
5 |
![]()
Artisan Partners
Milwaukee,
Wisconsin
|
-$12.9M |